Drug intelligence / Profile preview

Flumune C

Development stage: Unknown
Lead developer: Shanur Healthcare
Modality: Small Molecules
Administration: Oral

Overview

Flumune C is an over-the-counter (OTC) immune support product developed by Shanur Healthcare, a South African pharmaceutical company. It is formulated as sugar-free effervescent tablets containing 1000 mg of Vitamin C (ascorbic acid), 5 mg of Zinc, and Echinacea extract. The product is designed for daily use to support the immune system against the common cold and influenza symptoms. It dissolves in water to create a citrus-flavored drink and contains no preservatives or artificial colorants.

Brand names: Flumune C

Beyond the preview

Go deeper on Flumune C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flumune C.

Explore the full profile